Project Grant R35GM162431
- This $536,250 Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports computational method development to advance single-cell transcriptomic data analysis. Awarded to Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, the project runs from July 1, 2025 through June 30, 2027 and develops knowledge-guided algorithms designed to improve the detection and...
- Federal Project Grant Award Summary Duke University received a $482,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. The award funds the development of computational methods and workflows to advance single-particle cryo-electron tomography (SP-cryo-ET), a cutting-edge imaging technology for visualizing protein structures within cells...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $807,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, with completion anticipated by April 30, 2030. The Schmid Lab will conduct integrated experimental and computational systems biology research to characterize the structure, function, and evolution of gene regulatory...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $446,410 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2030. The award supports the development and validation of advanced statistical methodologies designed to identify disease subtypes, with specific application to sepsis research. The project delivers three...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $742,738 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective May 15, 2025, through February 28, 2030. This Maximizing Investigators' Research Award (MIRA) supports computational research focused on developing and refining methods for accurate computer simulations of enzyme function and biomolecular...
- Federal Grant Award Summary Duke University's Office of Research Administration received a Project Grant of $523,255 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 12, 2026, with completion scheduled for February 28, 2031. The award supports fundamental research investigating the mechanisms of transposon regulation and activation, with transposons comprising nearly 50% of the human genome...
- This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
- Federal Project Grant Award Summary Boston University received a $449,625 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 15, 2025, with a completion date of July 31, 2030. The award supports foundational research aimed at developing new computational and experimental approaches to measure and model gene expression trajectories at the single-cell level. The...
- Federal Grant Award Summary Emory University received a $384,722 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award supports the development of statistical methods and analytical tools for integrating multi-view, multi-section, and multi-sample spatial transcriptomics (ST) data to advance understanding of disease mechanisms. The...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $474,507 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through March 31, 2031. The award funds fundamental research on cell signaling mechanisms mediated by O-linked glycosylation, specifically investigating O-linked β-N-acetylglucosamine (O-GlcNAc), a ubiquitous...
Duke University's Office of Research Administration is executing a $444,125 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, effective May 1, 2026, through February 28, 2031, supports the development of advanced computational methods and bioinformatics software for analyzing spatial transcriptomics data at sub-cellular resolution with high gene coverage. The research team will deliver machine learning methods for supervised cell type mapping by integrating reference single-cell transcriptomics data, with comprehensive performance evaluation using single-cell RNA-based simulations and validation by tissue histology experts. Additionally, the project will produce unsupervised machine learning approaches for cell state discovery to identify spatial organization and regulatory mechanisms beyond traditional cell type classification, along with analytical methodologies to correct diffusion noise and identify direct cell-cell interactions in high-resolution spatial data. These computational tools and analytical approaches will be developed and validated across diverse tissue contexts, including tumor microenvironments and inflammatory tissues, to enable researchers to fully leverage the capabilities of emerging spatial transcriptomics technologies for genome-wide expression profiling.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $444.1k | 4/7/26 |